Pharmacology Watch – April 1, 2017
April 1, 2017
View Issues
-
Months After SPRINT, Clinicians Continue Debating Appropriate Blood Pressure Targets
Concerns linger that aggressive BP management might affect mobility in those > 75 years of age.
-
Antithrombotic Drug Use Associated with Higher Risk of Subdural Hematoma
This study suggests that the newer direct oral anticoagulants may be safer in this regard than warfarin therapy.
-
Popular Drug Could Help Prevent Type 2 Diabetes
Does liraglutide play a role in the prevention of type 2 diabetes?
-
Breakthrough in Rheumatoid Arthritis Treatment?
In a recent trial, baricitinib was associated with significant clinical improvements as compared with placebo and adalimumab.
-
Comparing Treatments for Atopic Dermatitis
A new interleukin-31 inhibitor is under evaluation for the treatment of atopic dermatitis.
-
A Possible New Hope for Leukemia Patients
Treatment with blinatumomab resulted in significantly longer overall survival than chemotherapy among adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.
-
FDA Action
The FDA has approved brodalumab to treat adults with moderate-to-severe plaque psoriasis.